{"transactions":[{"id":765614,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"Kania Edwin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T20:15:04.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":2922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 2,922 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":263732,"source":{"system":"sec-edgar","filing":"0001193125-26-236904","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000119312526236904/ownership.xml","form_type":"4"}},{"id":1134965,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T22:43:16.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":2134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 2,134 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":260810,"source":{"system":"sec-edgar","filing":"0000950170-25-077213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000095017025077213/ownership.xml","form_type":"4"}},{"id":1500112,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T21:30:16.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of May 23, 2025 or the date of the 2025 annual meeting of the stockholders of the Issuer, subject to continued service."}],"balance_after":1154,"derivative":{"exercise_price":137.53,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":1154},"source":{"system":"sec-edgar","filing":"0000950170-24-065396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000095017024065396/ownership.xml","form_type":"4"}},{"id":1500111,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T21:30:16.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 732 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":258676,"source":{"system":"sec-edgar","filing":"0000950170-24-065396","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000095017024065396/ownership.xml","form_type":"4"}},{"id":1874468,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T20:37:04.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":1916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of May 25, 2024 or the date of the 2024 annual meeting of the stockholders of the Issuer, subject to continued service."}],"balance_after":1916,"derivative":{"exercise_price":71.33,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":1916},"source":{"system":"sec-edgar","filing":"0000950170-23-024894","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000095017023024894/ownership.xml","form_type":"4"}},{"id":1874467,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T20:37:04.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":1193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 1,193 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":257944,"source":{"system":"sec-edgar","filing":"0000950170-23-024894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000095017023024894/ownership.xml","form_type":"4"}},{"id":1978994,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-02T22:00:29.000Z","date":"2023-02-28","kind":"other","acquired":true,"shares":96876,"price":79.76,"value":7726829.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person withdrew 96,876 shares of the Issuer from Kania 2021 GRAT B, a grantor retained annuity trust, in exchange for cash. The withdrawal of shares from the trust resulted in a decrease in the number of shares the reporting person beneficially owns indirectly through the trust and a corresponding increase in the number of shares the reporting person beneficially owns directly. The reporting person believes that his withdrawal of shares from the trust constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":256751,"source":{"system":"sec-edgar","filing":"0000899243-23-006756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924323006756/doc4.xml","form_type":"4"}},{"id":1978993,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-02T22:00:29.000Z","date":"2023-02-28","kind":"other","acquired":true,"shares":145601,"price":79.76,"value":11613135.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person withdrew 145,601 shares of the Issuer from Kania 2021 GRAT A, a grantor retained annuity trust, in exchange for cash. The withdrawal of shares from the trust resulted in a decrease in the number of shares the reporting person beneficially owns indirectly through the trust and a corresponding increase in the number of shares the reporting person beneficially owns directly. The reporting person believes that his withdrawal of shares from the trust constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":159875,"source":{"system":"sec-edgar","filing":"0000899243-23-006756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924323006756/doc4.xml","form_type":"4"}},{"id":2241563,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T20:32:37.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant, June 1, 2023, or the date of the following annual meeting of shareholders of the Company."}],"balance_after":13500,"derivative":{"exercise_price":28.12,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000899243-22-021201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924322021201/doc4.xml","form_type":"4"}},{"id":2491910,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T21:15:14.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":74062,"price":22.71,"value":1681948.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $22.65 to $22.75, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":302893,"source":{"system":"sec-edgar","filing":"0000899243-21-046299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321046299/doc4.xml","form_type":"4"}},{"id":2491909,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T21:15:14.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":25938,"price":22.14,"value":574267.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $21.65 to $22.64, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":228831,"source":{"system":"sec-edgar","filing":"0000899243-21-046299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321046299/doc4.xml","form_type":"4"}},{"id":2500392,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T11:05:57.000Z","date":"2021-11-19","kind":"other","acquired":true,"shares":48966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 17, 2021, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 17, 2021, OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000,\" together with OneLiberty 2000, the \"OneLiberty Funds\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty GP, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 19, 2021, OneLiberty GP effected a distribution with respect to these shares to its members, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"kind","element":"transactionCoding","label":"F4","text":"On November 17, 2021, OneLiberty Ventures, Inc. effected a distribution of these shares to its sole stockholder, without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 17, 2021, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 17, 2021, OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000,\" together with OneLiberty 2000, the \"OneLiberty Funds\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty GP, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 19, 2021, OneLiberty GP effected a distribution with respect to these shares to its members, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 17, 2021, OneLiberty Ventures, Inc. effected a distribution of these shares to its sole stockholder, without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."}],"balance_after":202893,"source":{"system":"sec-edgar","filing":"0000899243-21-045464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321045464/doc4.xml","form_type":"4"}},{"id":2500391,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T11:05:57.000Z","date":"2021-11-17","kind":"other","acquired":false,"shares":46142,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"OneLiberty Ventures, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On November 17, 2021, OneLiberty Ventures, Inc. effected a distribution of these shares to its sole stockholder, without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 19, 2021, OneLiberty GP effected a distribution with respect to these shares to its members, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-045464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321045464/doc4.xml","form_type":"4"}},{"id":2500390,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T11:05:57.000Z","date":"2021-11-17","kind":"gift","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"OneLiberty Ventures, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":46142,"source":{"system":"sec-edgar","filing":"0000899243-21-045464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321045464/doc4.xml","form_type":"4"}},{"id":2500389,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T11:05:57.000Z","date":"2021-11-19","kind":"other","acquired":false,"shares":3873,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By OneLiberty Partners 2000, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 19, 2021, OneLiberty GP effected a distribution with respect to these shares to its members, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 19, 2021, OneLiberty GP effected a distribution with respect to these shares to its members, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-045464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321045464/doc4.xml","form_type":"4"}},{"id":2500388,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T11:05:57.000Z","date":"2021-11-17","kind":"other","acquired":false,"shares":25234,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 17, 2021, OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000,\" together with OneLiberty 2000, the \"OneLiberty Funds\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty GP, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 17, 2021, OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000,\" together with OneLiberty 2000, the \"OneLiberty Funds\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty GP, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-045464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321045464/doc4.xml","form_type":"4"}},{"id":2500387,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T11:05:57.000Z","date":"2021-11-17","kind":"other","acquired":false,"shares":779571,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 17, 2021, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 17, 2021, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-045464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321045464/doc4.xml","form_type":"4"}},{"id":2688658,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T21:26:47.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant, May 27, 2022, or the date of the following annual meeting of shareholders of the Company."}],"balance_after":13500,"derivative":{"exercise_price":26.26,"expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000899243-21-021355","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924321021355/doc4.xml","form_type":"4"}},{"id":3311659,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T21:58:23.000Z","date":"2020-01-14","kind":"sale","acquired":false,"shares":117625,"price":20.0114,"value":2353840.925,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.155, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23847,"source":{"system":"sec-edgar","filing":"0000899243-20-001179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924320001179/doc4.xml","form_type":"4"}},{"id":3311658,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T21:58:23.000Z","date":"2020-01-10","kind":"sale","acquired":false,"shares":357375,"price":20.3427,"value":7269972.4125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.745, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":141472,"source":{"system":"sec-edgar","filing":"0000899243-20-001179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924320001179/doc4.xml","form_type":"4"}},{"id":3343518,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T22:01:11.000Z","date":"2019-12-12","kind":"other","acquired":true,"shares":3873,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By OneLiberty Partners 2000, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 12, 2019, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") distributed to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration, 390,000 shares of the Issuer's common stock. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 12, 2019, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") distributed to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration, 390,000 shares of the Issuer's common stock. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of OneLiberty 2000 and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":3873,"source":{"system":"sec-edgar","filing":"0000899243-19-029044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319029044/doc4.xml","form_type":"4"}},{"id":3343517,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T22:01:11.000Z","date":"2019-12-12","kind":"other","acquired":false,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 12, 2019, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") distributed to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration, 390,000 shares of the Issuer's common stock. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 12, 2019, OneLiberty Ventures Fund 2000, L.P. (\"OneLiberty 2000\") distributed to its limited partners and sole general partner, OneLiberty Partners 2000, LLC (\"OneLiberty GP\"), pro rata and without consideration, 390,000 shares of the Issuer's common stock. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of OneLiberty 2000 and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":779571,"source":{"system":"sec-edgar","filing":"0000899243-19-029044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319029044/doc4.xml","form_type":"4"}},{"id":3345336,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:40:47.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":100000,"price":18.8084,"value":1880840.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.75 to $18.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":498847,"source":{"system":"sec-edgar","filing":"0000899243-19-028978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028978/doc4.xml","form_type":"4"}},{"id":3345333,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":38366,"price":18.6548,"value":715710.0568,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.65 to $18.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flagship Fund IV-Rx. Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":8190766,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345332,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":199935,"price":18.6548,"value":3729747.438,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.65 to $18.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":31216399,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345331,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":4092,"price":18.9586,"value":77578.5912,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flagship Fund IV-Rx. Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":8229132,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345330,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":21325,"price":18.9586,"value":404292.145,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":31416334,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345329,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":27714,"price":18.9943,"value":526408.0302,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.90 to $19.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flagship Fund IV-Rx. Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":8233224,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345328,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":144423,"price":18.9942,"value":2743199.3466,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.90 to $19.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":31437659,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345327,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-09","kind":"other","acquired":false,"shares":1735720,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 9, 2019,  Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\") and Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC (\"Flagship Fund IV GP\"), pro rata and without consideration, 6,292,342 shares and 1,207,658 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 1,494,155 shares and 241,565 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr., each a manager of Flagship Fund IV GP, each received 598,847 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 9, 2019,  Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\") and Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC (\"Flagship Fund IV GP\"), pro rata and without consideration, 6,292,342 shares and 1,207,658 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 1,494,155 shares and 241,565 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr., each a manager of Flagship Fund IV GP, each received 598,847 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV GP. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Pioneering, he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV GP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345326,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-09","kind":"other","acquired":false,"shares":1207658,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 9, 2019,  Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\") and Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC (\"Flagship Fund IV GP\"), pro rata and without consideration, 6,292,342 shares and 1,207,658 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 1,494,155 shares and 241,565 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr., each a manager of Flagship Fund IV GP, each received 598,847 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 9, 2019,  Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\") and Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC (\"Flagship Fund IV GP\"), pro rata and without consideration, 6,292,342 shares and 1,207,658 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 1,494,155 shares and 241,565 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr., each a manager of Flagship Fund IV GP, each received 598,847 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flagship Fund IV-Rx. Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":8260938,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3345325,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":4,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":5,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T00:38:35.000Z","date":"2019-12-09","kind":"other","acquired":false,"shares":6292342,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 9, 2019,  Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\") and Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC (\"Flagship Fund IV GP\"), pro rata and without consideration, 6,292,342 shares and 1,207,658 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 1,494,155 shares and 241,565 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr., each a manager of Flagship Fund IV GP, each received 598,847 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 9, 2019,  Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\") and Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC (\"Flagship Fund IV GP\"), pro rata and without consideration, 6,292,342 shares and 1,207,658 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 1,494,155 shares and 241,565 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr., each a manager of Flagship Fund IV GP, each received 598,847 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":31582082,"source":{"system":"sec-edgar","filing":"0000899243-19-028975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924319028975/doc4.xml","form_type":"4"}},{"id":3384473,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-31T23:19:34.000Z","date":"2019-10-29","kind":"other","acquired":true,"shares":27799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pro rata distribution of shares of the Issuer's common stock from Flagship Ventures Fund IV General Partner LLC to its members. The aforementioned distribution was made in accordance with the exemption afforded by Rule 16a-9 of the Securities and Exchange Act of 1934, as amended."}],"balance_after":153928,"source":{"system":"sec-edgar","filing":"0000899243-19-026442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319026442/doc4.xml","form_type":"4"}},{"id":3384472,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-31T23:19:34.000Z","date":"2019-10-29","kind":"other","acquired":true,"shares":92796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution of shares of the Issuer's common stock from Flagship Ventures 2007 General Partner LLC to its members. The aforementioned distribution was made in accordance with the exemption afforded by Rule 16a-9 of the Securities and Exchange Act of 1934, as amended."}],"balance_after":126129,"source":{"system":"sec-edgar","filing":"0000899243-19-026442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319026442/doc4.xml","form_type":"4"}},{"id":3525682,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":895255,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by Flagship Ventures Opportunities Fund I, L.P. (\"Flagship Opportunities I\"). Flagship Ventures Opportunities Fund I General Partner LLC (\"Flagship Opportunities GP\") is the general partner of Flagship Opportunities I. Noubar B. Afeyan, Ph.D. serves as sole manager of Flagship Opportunities GP and may be deemed to possess sole voting and investment power with respect to all shares held by Flagship Opportunities I. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":486023},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525681,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":89525,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV-Rx. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":48602},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525680,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":358102,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":194409},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525679,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":151643,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV-Rx. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":82324},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525678,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":617914,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":335457},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525677,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":222506,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship Fund 2007\"). Flagship Ventures 2007 General Partner LLC (\"Fund 2007 GP\") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Fund 2007 GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship 2007 GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":120795},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525676,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":1005413,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV-Rx. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":545826},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525675,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":928074,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":503840},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525674,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":386697,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship Fund 2007\"). Flagship Ventures 2007 General Partner LLC (\"Fund 2007 GP\") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Fund 2007 GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship 2007 GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":209933},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525673,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":4153847,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2255074},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525672,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":1384615,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship Fund 2007\"). Flagship Ventures 2007 General Partner LLC (\"Fund 2007 GP\") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Fund 2007 GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship 2007 GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":751691},"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525671,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"purchase","acquired":true,"shares":500000,"price":20,"value":10000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by Flagship Ventures Opportunities Fund I, L.P. (\"Flagship Opportunities I\"). Flagship Ventures Opportunities Fund I General Partner LLC (\"Flagship Opportunities GP\") is the general partner of Flagship Opportunities I. Noubar B. Afeyan, Ph.D. serves as sole manager of Flagship Opportunities GP and may be deemed to possess sole voting and investment power with respect to all shares held by Flagship Opportunities I. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":986023,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525670,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":486023,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by Flagship Ventures Opportunities Fund I, L.P. (\"Flagship Opportunities I\"). Flagship Ventures Opportunities Fund I General Partner LLC (\"Flagship Opportunities GP\") is the general partner of Flagship Opportunities I. Noubar B. Afeyan, Ph.D. serves as sole manager of Flagship Opportunities GP and may be deemed to possess sole voting and investment power with respect to all shares held by Flagship Opportunities I. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":486023,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525669,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":48602,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV-Rx. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":676752,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525668,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":194409,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":3288780,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525667,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":82324,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV-Rx. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":628150,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525666,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":335457,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":3094371,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525665,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":120795,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship Fund 2007\"). Flagship Ventures 2007 General Partner LLC (\"Fund 2007 GP\") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Fund 2007 GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship 2007 GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":1761029,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525664,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":545826,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV-Rx. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":545826,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525663,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":503840,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":2758914,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525662,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":209933,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship Fund 2007\"). Flagship Ventures 2007 General Partner LLC (\"Fund 2007 GP\") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Fund 2007 GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship 2007 GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":1640234,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525661,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":2255074,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":2255074,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3525660,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":3,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":5,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":6,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69365,"kind":"person","name":"Flagship Ventures Opportunities Fund I General Partner LLC","position":7,"cik":"0001725004","reported_name":"Flagship Ventures Opportunities Fund I General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":8,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":9,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":10,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T20:18:59.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":751691,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship Fund 2007\"). Flagship Ventures 2007 General Partner LLC (\"Fund 2007 GP\") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Fund 2007 GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship 2007 GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":1430301,"source":{"system":"sec-edgar","filing":"0001104659-19-029735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1222012/000110465919029735/a4.xml","form_type":"4"}},{"id":3537819,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":200000,"ownership":{"direct":false,"nature":"OneLiberty\nVentures, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57142},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537818,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5714},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537817,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":31383,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8966},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537816,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-1 Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":38081,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3006},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537815,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":506,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537814,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":501048,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":143156},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537813,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":980000,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537812,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":1119394,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":319827},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537811,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-1 Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":791501,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":62475},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537810,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":10756,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":793},"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537809,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"purchase","acquired":true,"shares":33333,"price":16,"value":533328.0,"ownership":{"direct":true},"balance_after":33333,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537808,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":true,"shares":57142,"ownership":{"direct":false,"nature":"OneLiberty Ventures, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":57142,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537807,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":true,"shares":17724,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":25234,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537806,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"exercise","acquired":true,"shares":806252,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000,\nL.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, such Series C, D and F preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series A-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $2.50 per share by a conversion price of $9.680, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the Merger Agreement, each outstanding share of Series B-1 preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms, determined by dividing the original issue price of $3.416 per share by a conversion price of $12.365, and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1169571,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537805,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":7511,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":7511,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537804,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":26288,"ownership":{"direct":false,"nature":"By OneLiberty Advisors Fund 2000, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537803,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":363320,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000,\nL.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":363320,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3537802,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":44658,"kind":"person","name":"Kania Edwin","position":1,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:43:56.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":1271619,"ownership":{"direct":false,"nature":"By OneLiberty Ventures 2000, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Edwin M. Kania, Jr. is a manager of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Ventures 2000, L.P. (\"OneLiberty 2000\") and OneLiberty Advisors Fund 2000, L.P. (\"OneLiberty Advisors 2000\" and together with OneLiberty 2000, the \"OneLiberty Funds\"). Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-012293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255927/000089924319012293/doc4.xml","form_type":"4"}},{"id":3608662,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":3,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":4,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":5,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":159412,"kind":"organization","name":"Cadena LLC","position":6,"cik":"0001768776","reported_name":"Cadena LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":7,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":8,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2019-03-06T16:43:12.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":562407,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Flagship Ventures Fund IV, L.P. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP.  Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":281203},"source":{"system":"sec-edgar","filing":"0000899243-19-006452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319006452/doc4.xml","form_type":"4"}},{"id":3608661,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":3,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":4,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":5,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":159412,"kind":"organization","name":"Cadena LLC","position":6,"cik":"0001768776","reported_name":"Cadena LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":7,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":8,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2019-03-06T16:43:12.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":347173,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship 2007\"). Flagship Ventures 2007 General Partner LLC (\"Flagship 2007 GP\") is the general partner of Flagship 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship 2007 LLC. While Mr. Kania is retired from Flagship Pioneering, Inc., he continue to serve as a manager of Flagship 2007 GP.  Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":173586},"source":{"system":"sec-edgar","filing":"0000899243-19-006452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319006452/doc4.xml","form_type":"4"}},{"id":3608660,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":3,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":4,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":5,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":159412,"kind":"organization","name":"Cadena LLC","position":6,"cik":"0001768776","reported_name":"Cadena LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":7,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":8,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-03-06T16:43:12.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":1331816,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Flagship Ventures Fund IV, L.P. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP.  Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":665908},"source":{"system":"sec-edgar","filing":"0000899243-19-006452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319006452/doc4.xml","form_type":"4"}},{"id":3608659,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":3,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":4,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":5,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":159412,"kind":"organization","name":"Cadena LLC","position":6,"cik":"0001768776","reported_name":"Cadena LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":7,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":8,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T16:43:12.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":281203,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Flagship Ventures Fund IV, L.P. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP.  Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":947111,"source":{"system":"sec-edgar","filing":"0000899243-19-006452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319006452/doc4.xml","form_type":"4"}},{"id":3608658,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":3,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":4,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":5,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":159412,"kind":"organization","name":"Cadena LLC","position":6,"cik":"0001768776","reported_name":"Cadena LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":7,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":8,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T16:43:12.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":173586,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series A-1 Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund 2007, L.P. (\"Flagship 2007\"). Flagship Ventures 2007 General Partner LLC (\"Flagship 2007 GP\") is the general partner of Flagship 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship 2007 LLC. While Mr. Kania is retired from Flagship Pioneering, Inc., he continue to serve as a manager of Flagship 2007 GP.  Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":216451,"source":{"system":"sec-edgar","filing":"0000899243-19-006452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319006452/doc4.xml","form_type":"4"}},{"id":3608657,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":2,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":3,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107299,"kind":"organization","name":"Flagship Ventures 2007 General Partner LLC","position":4,"cik":"0001508053","reported_name":"Flagship Ventures 2007 General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154134,"kind":"organization","name":"Flagship Ventures Fund 2007, L.P.","position":5,"cik":"0001508052","reported_name":"Flagship Ventures Fund 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":159412,"kind":"organization","name":"Cadena LLC","position":6,"cik":"0001768776","reported_name":"Cadena LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":7,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":8,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T16:43:12.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":665908,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Flagship Ventures Fund IV, L.P. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP.  Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein."}],"balance_after":665908,"source":{"system":"sec-edgar","filing":"0000899243-19-006452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319006452/doc4.xml","form_type":"4"}},{"id":3732255,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":21496,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21496},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732254,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":85989,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":85989},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732253,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":1428432,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1428432},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732252,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":5713739,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5713739},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732251,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":6195632,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6195632},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732250,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":24782551,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24782551},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732249,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":1823036,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1823036},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732248,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":7292145,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7292145},"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732247,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":21496,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":9468596,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732246,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":85989,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series D Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45854 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":37874424,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732245,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":1428432,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":9447100,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732244,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":5713739,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series C Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45853 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":37788435,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732243,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":6195632,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":8018668,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732242,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":24782551,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":32074696,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732241,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":1823036,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV-Rx, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flagship Ventures Fund IV-Rx, L.P. (\"Flagship Fund IV-Rx\"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. While Mr. Kania is retired from Pioneering he continues to serve as a manager of the Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":1823036,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3732240,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":44731,"kind":"person","name":"Afeyan Noubar","position":1,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":2,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63978,"kind":"organization","name":"Flagship Pioneering, LLC","position":3,"cik":"0001400240","reported_name":"Flagship Pioneering Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":4,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":5,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":6,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":7,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:20:14.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":7292145,"ownership":{"direct":false,"nature":"By: Flagship Ventures Fund IV, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.0001 par value per share (\"Common Stock\") based on an applicable conversion ratio of 0.45576 upon the closing of the Issuer's initial public offering on December 11, 2018. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Flagship Ventures Fund IV, L.P. (\"Flagship Fund IV\"). Flagship Ventures Fund IV General Partner LLC (\"Flagship Fund IV GP\") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc. (\"Pioneering\"), he continues to serve as a manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":7292145,"source":{"system":"sec-edgar","filing":"0000899243-18-030859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030859/doc4.xml","form_type":"4"}},{"id":3862955,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":2,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":3,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":4,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69364,"kind":"person","name":"Flagship Ventures Fund V, L.P.","position":5,"cik":"0001627639","reported_name":"Flagship Ventures Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109677,"kind":"organization","name":"Flagship V VentureLabs Rx Fund, L.P.","position":6,"cik":"0001724939","reported_name":"Flagship V VentureLabs Rx Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":7,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":8,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":9,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C  Preferred Stock","published_at":"2018-07-23T16:34:53.000Z","date":"2018-07-20","kind":"exercise","acquired":false,"shares":781860,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Flagship Ventures Opportunities Fund I, L.P. (\"Flagship Opportunities Fund I\"). Flagship Ventures Opportunities Fund I General Partner LLC (\"Flagship Opportunities GP\") is the general partner of Flagship Opportunities I. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Opportunities GP and may be deemed to possess sole voting and investment power with respect to all shares held by Flagship Opportunities I. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":781860},"source":{"system":"sec-edgar","filing":"0001104659-18-046534","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1724939/000110465918046534/a4.xml","form_type":"4"}},{"id":3862954,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":2,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":3,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":4,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69364,"kind":"person","name":"Flagship Ventures Fund V, L.P.","position":5,"cik":"0001627639","reported_name":"Flagship Ventures Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109677,"kind":"organization","name":"Flagship V VentureLabs Rx Fund, L.P.","position":6,"cik":"0001724939","reported_name":"Flagship V VentureLabs Rx Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":7,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":8,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":9,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C  Preferred Stock","published_at":"2018-07-23T16:34:53.000Z","date":"2018-07-20","kind":"exercise","acquired":false,"shares":195466,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Flagship V VentureLabs Rx Fund, L.P. (\"VentureLabs Rx V\"). Flagship Fund V GP is the general partner of VentureLabs Rx V. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund V GP and may be deemed to possess sole voting and investment power with respect to all shares held by VentureLabs Rx V. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":195466},"source":{"system":"sec-edgar","filing":"0001104659-18-046534","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1724939/000110465918046534/a4.xml","form_type":"4"}},{"id":3862953,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":97142,"kind":"organization","name":"Flagship Ventures Fund IV General Partner LLC","position":1,"cik":"0001508051","reported_name":"Flagship Ventures Fund IV General Partner LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157564,"kind":"organization","name":"Flagship VentureLabs IV, LLC","position":2,"cik":"0001642578","reported_name":"Flagship VentureLabs IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111426,"kind":"organization","name":"Flagship Ventures Fund IV, L.P.","position":3,"cik":"0001503559","reported_name":"Flagship Ventures Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":126697,"kind":"organization","name":"Flagship Ventures Fund IV-Rx, L.P.","position":4,"cik":"0001590973","reported_name":"Flagship Ventures Fund IV-Rx, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69364,"kind":"person","name":"Flagship Ventures Fund V, L.P.","position":5,"cik":"0001627639","reported_name":"Flagship Ventures Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109677,"kind":"organization","name":"Flagship V VentureLabs Rx Fund, L.P.","position":6,"cik":"0001724939","reported_name":"Flagship V VentureLabs Rx Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69366,"kind":"person","name":"Flagship Ventures Opportunities Fund I, L.P.","position":7,"cik":"0001677345","reported_name":"Flagship Ventures Opportunities Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44731,"kind":"person","name":"Afeyan Noubar","position":8,"cik":"0001222012","reported_name":"AFEYAN NOUBAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44658,"kind":"person","name":"Kania Edwin","position":9,"cik":"0001255927","reported_name":"KANIA EDWIN M JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C  Preferred Stock","published_at":"2018-07-23T16:34:53.000Z","date":"2018-07-20","kind":"exercise","acquired":false,"shares":195466,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock automatically convert into common stock upon the closing of the Issuer's initial public offering held on July 20, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Flagship Ventures Fund V, L.P. (\"Flagship Fund V\"). Flagship Ventures Fund V General Partner LLC (\"Flagship Fund V GP\") is the general partner of Flagship Fund V. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund V GP and may be deemed to possess sole voting and investment power with respect to all shares held by Flagship Fund V. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":195466},"source":{"system":"sec-edgar","filing":"0001104659-18-046534","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1724939/000110465918046534/a4.xml","form_type":"4"}}],"next_cursor":"2018-07-23T16:34:53.000000Z,3862953"}